The Weekly Dose: Cannabis, Contraceptives, and Advances in Alzheimer Disease and Gonorrhea Treatment
Clinical insights on cannabis and dementia, hormonal contraceptives and postpartum depression, the FDA-approved blood test for Alzheimer disease, more.
In this episode of Weekly Dose, we cover the latest clinical research, including a study linking cannabis-related ED visits to a higher risk of dementia, and new findings on hormonal contraceptives and postpartum depression. We also explore the FDA’s approval of the first blood test for Alzheimer disease diagnosis, gepotidacin as an oral treatment for gonorrhea, and the growing global burden of atopic dermatitis in older adults. Tune in for a comprehensive overview of these important studies and their clinical implications.
Recent Videos
Related Content
